Source Natural

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE679C01027
  • NSEID:
  • BSEID: 531398
INR
138.90
0.25 (0.18%)
BSENSE

Dec 04

BSE+NSE Vol: 294

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 64.57% vs 37.96% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 15.00% vs 23.97% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 199.38% vs -23.07% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 67.23% vs -18.13% in Mar 2024

Compare Profit and Loss Results of Source Natural
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
44.00
44.00
0.00
0.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
44.00
44.00
0.00
0.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
5.00
-6.00
-120.00%
Raw Materials Consumed
34.00
33.00
1.00
3.03%
Power & Fuel Cost
0.00
1.00
-1.00
-100.00%
Employee Cost
3.00
15.00
-12.00
-80.00%
Operating Expenses
1.00
3.00
-2.00
-66.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39.00
63.00
-24.00
-38.10%
Operating Profit (PBDIT) excl Other Income
5.00
-18.00
23.00
127.78%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
5.00
-15.00
20.00
133.33%
Interest
0.00
7.00
-7.00
-100.00%
Profit before Depriciation and Tax
4.00
-22.00
26.00
118.18%
Depreciation
1.00
0.00
1.00
0%
Profit Before Taxation & Exceptional Items
3.00
-22.00
25.00
113.64%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3.00
-22.00
25.00
113.64%
Provision for Tax
0.00
-5.00
5.00
100.00%
Profit After Tax
2.00
-17.00
19.00
111.76%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
11.00
-49.00
60.00
122.45%
Profit Available for appropriations
14.00
-66.00
80.00
121.21%
Appropriations
14.00
-66.00
80.00
121.21%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.51
-3.95
8.46
214.18%
Profit And Loss - Net Sales
Net Sales 44.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 64.57% vs 37.96% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.15 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.00% vs 23.97% in Mar 2024

Profit And Loss - Interest
Interest 0.62 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 199.38% vs -23.07% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 2.90 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 67.23% vs -18.13% in Mar 2024